MORGAN STANLEY - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$664,184
+144.9%
259,447
+139.2%
0.00%
Q2 2023$271,188
-1.7%
108,475
-17.4%
0.00%
Q1 2023$275,770
+321.9%
131,319
+211.4%
0.00%
Q4 2022$65,371
-66.8%
42,175
-34.7%
0.00%
Q3 2022$197,000
+9.4%
64,570
+13.1%
0.00%
Q2 2022$180,000
+63.6%
57,089
+46.1%
0.00%
Q1 2022$110,000
-10.6%
39,076
+42.6%
0.00%
Q4 2021$123,000
-47.7%
27,404
-2.9%
0.00%
Q3 2021$235,00028,2360.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders